News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Sepp-Lorenzino Laura
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/06/2023 |
4
| Sepp-Lorenzino Laura (EVP, Chief Scientific Officer) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Sold 2,508 shares
@ $37.21, valued at
$93.3k
Sold 1,641 shares
@ $38.22, valued at
$62.7k
Sold 689 shares
@ $39.1, valued at
$26.9k
|
|
| 01/04/2023 |
4
| Sepp-Lorenzino Laura (EVP, Chief Scientific Officer) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Exercised 3,500 restricted stock units
@ $0 |
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2021 |
4
| Sepp-Lorenzino Laura (EVP, Chief Scientific Officer) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 84,000 options to buy
@ $57.71, valued at
$4.8M
Granted 14,000 restricted stock units
@ $0 |
|
| 11/24/2020 |
4
| Sepp-Lorenzino Laura (Director) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Granted 31,000 options to buy
@ $21.77, valued at
$674.9k
|
|
| 11/24/2020 |
3
| Sepp-Lorenzino Laura (Director) has filed a Form 3 on Taysha Gene Therapies, Inc. |
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2019 |
4
| Sepp-Lorenzino Laura (EVP, Chief Scientific Officer) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $14.25, valued at
$2.1M
|
|
| 05/29/2019 |
3
| Sepp-Lorenzino Laura (EVP, Chief Scientific Officer) has filed a Form 3 on Intellia Therapeutics, Inc. |
|
|